The Tudor Dixon Podcast: RFK Jr., Big Pharma, and the Hidden Risks of SSRIs in Pregnancy

Date: September 5, 2025
Host: Tudor Dixon
Guest: Dr. Adam Jurado, Chief of Maternal Fetal Medicine, Metro West Medical Center

Episode Overview

This episode brings timely scrutiny to the influence of the pharmaceutical industry in public health debates, focusing especially on the prescribing and safety of SSRIs (Selective Serotonin Reuptake Inhibitors) during pregnancy. Host Tudor Dixon welcomes Dr. Adam Jurado—a leading expert in maternal-fetal medicine and outspoken voice on medication safety in pregnancy—to discuss new research, the pharmaceutical "playbook," regulatory failures, and the urgent need for informed consent.

Key Discussion Points

1. Battle Lines: Pharma vs. the "Maha Movement"

• The current healthcare debate is drawn with sharp lines, where critics of pharmaceutical industry practices are often ostracized.
• Tudor observes: “There’s like this black and white line. You’re either on one side or the other of this issue. You cannot cross that line.” (03:14)

2. Chemicals Have Consequences

• Dr. Jurado outlines the non-negotiable biological reality: pharmaceuticals are chemicals, synthesized in factories, and they "have consequences" in the body—especially during pregnancy.
• Quote: “They go into the mom, they cross over the placenta, they go into the baby, and… they have chemical effects.” (06:07)
• He stresses compassionate, informed care: “Part of compassionate care is proper information accurately informing patients and the public.” (05:13)

3. How Pharma Sells: The Playbook

• Dr. Jurado highlights a recurring model:
  • Pharma creates fear around a condition (e.g., depression in pregnancy)
  • Offers a drug as a near-universally safe and effective remedy
  • Downplays risks, maximizing sales until post-market studies contradict the initial claims
• Quote: “What people have to remember is that the sales pitch is designed to increase sales. But it’s not the truth.” (09:22)

4. SSRIs in Pregnancy: What Does the Science Say?

• SSRIs are widely marketed for use in pregnant women based on the idea that untreated depression harms pregnancy outcomes.
• Actual scientific evidence points to increased risks for miscarriage, birth defects, preterm birth, low birth weight, preeclampsia, postpartum hemorrhage, and neonatal complications:
  • “That’s simply what the science shows… we see increased rates… of miscarriage, of birth defects, increased rates of preterm birth…” (10:23)
• Long-term studies are now showing increased rates of depression, language disorders, ADHD, and autism in exposed children.

5. The Challenge of Post-Approval Oversight

• Dr. Jurado discusses the difficulty in having drugs reevaluated after regulatory approval, using the drug Makena as a case study:
  • Initial shaky evidence, rapid rollout, later research showing ineffectiveness, yet years before its removal.
  • “I like the way you explained that—going before the wizard of Oz…” (13:23)
• He warns: “It took 20 years, more than 20 years to get [vaginal mesh] off the market.” (15:56)

6. Cultural & Professional Resistance to Questioning

• Even doctors are slow to publicly question consensus due to fear or professional risk.
• Quote: “A conventional wisdom develops or a scientific consensus, and then physicians become afraid to be seen as running against that… and so then they self censor.” (16:39)
• Science requires dissent and open discussion—even (or especially) when it challenges prevailing dogma.

7. Tangibles of SSRI Effects: Fetal and Neonatal Findings

• Dixon notes, “You can actually tell by looking at an ultrasound if the baby’s mother is on an SSRI.” (22:01)
• Dr. Jurado explains:
  • Altered, jittery fetal movements in SSRIs-exposed pregnancies have been documented via ultrasound and correspond to postnatal agitation and withdrawal ("newborn behavioral syndrome").
  • New studies even show longer umbilical cords—possibly due to increased fetal motion. (24:45)

8. Link to Rising Childhood Mental Health Issues

• Dixon raises the controversy: Are SSRIs in pregnancy partly responsible for recent surges in autism, ADHD, and neurodevelopmental disorders? (26:06)
• Dr. Jurado discusses animal studies—exposing pregnant rodents to SSRIs leads to altered social and sexual behavior in offspring.
• “Americans, modern-day Americans are… the most heavily medicated human beings that have ever lived on the planet.” (28:02)

9. Should This Be a Five-Alarm Fire?

• Both Dixon and Jurado express frustration that mounting evidence is not prompting urgent action or warnings.
• Dr. Jurado: “Never before in human history have we chemically altered developing babies’ brains in this way.” (30:44)
• 12 MRI studies have now shown altered brain development in human infants exposed to SSRIs in utero. (31:47)

10. Pharma’s Diversion Tactics

• When challenged on safety, pharma shifts the narrative to focus on the severity of the underlying condition (e.g., untreated depression), not the risks of their product.
• Quote: “This is sort of a pharmaceutical technique… to divert attention away from the issue at hand.” (32:58)

11. Sexual Dysfunction: A Taboo but Devastating Consequence

• Dixon and Dr. Jurado discuss Post-SSRI Sexual Dysfunction (PSSD), affecting some adolescents and adults long-term:
  • “There are people who take these, and sometimes… there is permanent sexual dysfunction. Sometimes they can get off the drug and that can be reversed. But too often they are not told ahead of time that this could happen.” (35:03)
  • PSSD can devastate relationships and wellbeing; it is grossly under-discussed in informed consent.

12. The Call for Informed Consent

• Many patients only discover severe side effects after the fact, including permanent changes.
• Dixon: “If I had known these were the side effects I wouldn’t have originally agreed to take [SSRIs].” (41:59)
• Jurado: “I never want my patients to come back… and say, ‘Boy, you didn’t really counsel us about those drugs and what you were seeing in the research literature.’” (44:03)
• Both call for more transparency—“getting proper information out to patients and the public.” (44:18)

Notable Quotes & Timestamps

• “Chemicals have consequences.”
  — Dr. Adam Jurado (06:29)
• “The sales pitch… is not actually supported by the scientific evidence.”
  — Dr. Adam Jurado (09:54)
• “Americans, modern-day Americans are… the most heavily medicated human beings that have ever lived on the planet.”
  — Dr. Adam Jurado (28:02)
• “Never before in human history have we chemically altered developing babies’ brains in this way.”
  — Dr. Adam Jurado (30:44)
• “Science is dissent—dissent is essentially the heart of science.”
  — Dr. Adam Jurado (17:15)
• “If I had known these were the side effects I wouldn’t have originally agreed to take [SSRIs].”
  — Tudor Dixon (41:59)
• “It’s not about pill shaming… It’s just about getting proper information out to patients and the public.”
  — Dr. Adam Jurado (44:18)

Important Timestamps

• 03:09 — Tudor Dixon sets the stage: medicine’s black-and-white debates
• 05:31 — Dr. Jurado introduces "chemicals have consequences"
• 08:23 — The emotional toll and self-blame experienced by pregnant women
• 09:22 — Breaking down pharma sales tactics
• 10:23 — The real science on SSRIs and pregnancy risks
• 13:17 — The Makena drug case study
• 16:39 — The problem of censorship and self-censorship
• 21:07 — The impact of SSRIs visible on fetal ultrasound
• 26:06 — Linking SSRI exposure to changes in childhood behavior
• 30:44 — MRI/EEG evidence of altered infant brain development
• 32:58 — How pharma sidesteps safety questions
• 35:03 — Post-SSRI Sexual Dysfunction in depth
• 41:59 — Why patients needed more transparency
• 44:03 — Dr. Jurado on his duty to fully inform patients

Tone & Language

The episode is urgent and forthright, with Dr. Jurado calmly but firmly dispelling industry narratives and emphasizing compassion, responsibility, and scientific skepticism. Tudor Dixon matches his conviction with stories from her own life and the broader community, inviting empathy for both patients and healthcare professionals.

Summary Takeaways

• The existing pharmaceutical model often prioritizes sales over robust and ongoing safety monitoring.
• SSRIs during pregnancy carry documented risks—to both child and mother—which are often minimized or overlooked.
• Informed consent is paramount; clinicians must provide transparent, up-to-date information about known risks and alternatives.
• Dissent and skepticism are vital to scientific progress and patient safety—self-censorship in medicine is dangerous.
• There is a growing need for a broader re-evaluation of how medications are marketed, prescribed, and monitored in all populations, especially vulnerable ones like pregnant women and developing children.

For those who want to understand what’s really at stake in the debate over SSRIs, pregnancy, and pharmaceutical industry practices, this episode is essential listening.